Primaquine-induced differential gene expression analysis in mice liver using DNA microarrays

Toxicology

Volumn 239, Issue 1-2, 2007, Pages 96-107

  Noel, Sanjeev ^a   Sharma, Sharad ^a   Shanker, Rishi ^b   Rath, Srikanta Kumar ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

Author keywords

8 Aminoquinoline; Differential gene expression; Microarray; Primaquine; Toxicogenomics

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; EOSIN; HEMATOXYLIN; MESSENGER RNA; PRIMAQUINE; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CELL ADHESION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DNA MICROARRAY; ENZYME ACTIVITY; GENE EXPRESSION; HEMATOPOIESIS; HISTOLOGY; LIVER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; TRANSCRIPTION REGULATION;

ADMINISTRATION, ORAL; ALANINE TRANSAMINASE; ANIMALS; ANIMALS, OUTBRED STRAINS; ANTIMALARIALS; ASPARTATE AMINOTRANSFERASES; GENE EXPRESSION; GENE EXPRESSION PROFILING; LIVER; MALE; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE STRESS; PRIMAQUINE; RNA, MESSENGER; TOXICOGENETICS;

MUS; MUS MUSCULUS; PLASMODIUM OVALE; PLASMODIUM VIVAX;

EID: 34548035168     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2007.06.098     Document Type: Article

References (22)

1. Baker J.K., McChesney J.D., Hufford C.D., and Clark A.M. High-performance liquid chromatographic analysis of the metabolism of primaquine and the identification of a new mammalian metabolite. J. Chromatogr. 230 (1982) 69-77
2. Bates M.D., Meshnick S.R., Sigler C.I., Leland P., and Hollingdale M.R. In vitro effects of primaquine and primaquine metabolites on exoerythrocytic stages of Plasmodium berghei. Am. J. Trop. Med. Hyg. 42 (1990) 532-537
3. Cohen R.J., Sachs J.R., Wicker D.J., and Conrad M.E. Methemoglobinemia provoked by malarial chemoprophylaxis in Vietnam. N. Engl. J. Med. 279 (1968) 1127-1131
4. Dahlquist K.D., Salomonis N., Vranizan K., Lawlor S.C., and Conklin B.R. GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat. Genet. 31 (2002) 19-20
5. Doherty J.F., Day J.H., Warhurst D.C., and Chiodini P.L. Treatment of Plasmodium vivax malaria-time for a change?. Trans. R. Soc. Trop. Med. Hyg. 91 (1997) 76
6. Doniger S.W., Salomonis N., Dahlquist K.D., Vranizan K., Lawlor S.C., and Conklin B.R. MAPPFinder: using gene ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol. 4 (2003) R.7.1-R.7.12
7. Dvorak H.F. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J. Clin. Oncol. 20 (2002) 4368-4380
8. Fletcher K.A., Evans D.A., Gilles H.M., Greaves J., Bunnag D., and Harinasuta T. Studies on the pharmacokinetics of primaquine. Bull. World Health Organ. 59 (1981) 407-412
9. Hanakahi L.A., Dempsey L.A., Li M.J., and Maizels N. Nucleolin is one component of the B cell specific transcription factor and switch region binding protein, LR1. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 3605-3610
10. Jaeschke H., Gores G.J., Cederbaum A.I., Hinson J.A., Pessayre D., and Lemasters J.J. Mechanisms of hepatotoxicity. Toxicol. Sci. 65 (2002) 166-176
11. Karbwang J., and Harinasuta T. Distribition of drug resistance. In: Karbwang J., and Harinasuta T. (Eds). Chemotherapy of Malaria in Southeast Asia (1992), Roumtassana, Bangkok 48-72
12. Kyzas P.A., Stefanou D., Batstatou A., and Agnantis N.J. Potential autocrine function of vascular endothelial growth factor in head and neck cancer via vascular endothelial growth factor receptor-2. Mod. Pathol. 18 (2005) 485-494
13. Mihaly G.W., Ward S.A., Edwards G., Orme M.L., and Breckenridge A.M. Pharmacokinetics of primaquine in man: identification of the carboxylic acid derivative as a major plasma metabolite. Br. J. Clin. Pharmacol. 17 (1984) 441-446
14. Minami K., Saito T., Narahara M., Tomita H., Kato H., Sugiyama H., Katoh M., Nakajima M., and Yokoi T. Relationship between hepatic gene expression profiles and hepatotoxicity in five typical hepatotoxicant-administered rats. Toxicol. Sci. 87 (2005) 296-305
15. Onesto C., Berra E., Grepin R., and Pages G. Poly(A)-binding protein-interacting protein 2, a strong regulator of vascular endothelial growth factor mRNA. J. Biol. Chem. 279 (2004) 34217-34226
16. Rang H.P., Dale M.M., Ritter J.M., and Moore P.K. Pharamacology (2003), Churchill Livingstone, United Kingdom
17. Saeed A.I., Sharov V., White J., Li J., Liang W., Bhagabati N., Braisted J., Klapa M., Currier T., Thiagarajan M., Sturn A., Snuffin M., Rezantsev A., Popov D., Ryltsov A., Kostukovich E., Borisovsky I., Liu Z., Vinsavich A., Trush V., and Quackenbush J. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34 (2003) 374-378
18. Symposium (various authors), 1987. Primaquine: pharmacokinetics, metabolism, toxicity and activity. In: Wernsdorfer, W.H., Trigg, P.I. (Eds.), Proceeding of a Meeting of the Scientific Working Group on the Chemotherapy of Malaria. Wiley, New York.
19. Tarlov A.R., Brewer G.J., Carson P.E., and Alving A.S. Primaquine sensitivity. Glucose-6-phosphate dehydrogenase deficiency: an inborn error of metabolism of medical and biological significance. Arch. Intern. Med. 109 (1962) 209-234
20. Warrell D.A. Treatment and prevention of malaria. In: Gilles H.M., Warrell D.A., and Bruce-Chwatt (Eds). Essential Malariology. third ed. (1993), Arnold, London 164-195
21. WHO. Practical Chemotherapy of Malaria (1990), World Health Organization, Geneva (technical report series no. 805)
22. Wong B.S., Liu S., Schultz G.A., and Rancourt D.E. Subtilisin proprotein convertase-6 expression in the mouse uterus during implantation and artificially induced decidualization. Mol. Reprod. Dev. 61 (2002) 453-459